Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
61.05B
Market cap61.05B
Price-Earnings ratio
23.64
Price-Earnings ratio23.64
Dividend yield
0.74%
Dividend yield0.74%
Average volume
1.39M
Average volume1.39M
High today
$321.40
High today$321.40
Low today
$317.65
Low today$317.65
Open price
$317.80
Open price$317.80
Volume
143.78K
Volume143.78K
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $319.91. The company's market cap stands at 61.05B, with a P/E ratio of 23.64 and a dividend yield of 0.74%.

As of 2026-08-24, Cencora, Inc.(COR) stock has fluctuated between $317.65 and $321.40. The current price stands at $319.91, placing the stock +0.7% above today's low and -0.5% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 143.78K, against a daily average of 1.39M.

During the past year, Cencora, Inc.(COR) stock moved between $244.82 at its lowest and $377.54 at its peak.

During the past year, Cencora, Inc.(COR) stock moved between $244.82 at its lowest and $377.54 at its peak.

COR News

Fortune 2d
Cencora Q2 2026 Earnings Call Transcript - Fortune

...

Cencora Q2 2026 Earnings Call Transcript - Fortune
Nasdaq 5d
Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

Key Points This pair of stocks offer inflation exposure but they don't need rising prices to succeed. McKesson can benefit when certain pharmaceutical prices...

Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
TipRanks 5d
Cencora initiated with a Sector Perform at RBC Capital

RBC Capital initiated coverage of Cencora (COR) with a Sector Perform rating and $330 price target The company’s “pharma-aligned and integrated platform” will b...

Analyst ratings

74%

of 19 ratings
Buy
73.7%
Hold
26.3%
Sell
0%

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.